Astura Medical Reveals New Products Launching at NASS 2022: An Interview with CEO Joel Gambrell

 In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO for Astura Medical, shares the series of new products launching at NASS and, specifically, reveals what makes Astura’s new Integrated Expandable ALIF System, El Capitan, truly differentiated.

Since the Company was founded in 2014, Astura Medical has achieved fast growth, established a reputation for elegance and quality in its product offering and taken a different methodology to both product development and business operations. In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO, provides insight on how Astura’s R&D process is unique, unveils why Astura’s approach to custom implants offers the most real-time precision and reveals the distinctions that make the new Integrated Expandable ALIF System, El Capitan, truly differentiated. In addition to El Capitan, Astura Medical will be launching several other new technologies at the North American Spine Society’s (NASS) annual 2022 meeting in Chicago. 

SmartTRAK's spine experts will be roaming the floor at NASS 2022, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest news and innovations in the Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.  If you would like to book a meeting with us at NASS, just click here.

Continue reading to find out how to download a complete transcript of SmartTRAK's interview with CEO Joel Gambrell.

SmartTRAK: Having been in spine for quite a long time, you’ve experienced many different approaches to R&D and bringing new products to market. Going from a small player with a couple of elegant products to a profitable, high-growth spine company offering a complete portfolio in just a handful of years takes something really special. What has been Astura’s recipe for success? Continue reading to find out how to download a complete transcript of SmartTRAK's interview with CEO Joel Gambrell.

Joel Gambrell: In general, it’s how we think about the market, we won't take a project on if we don't believe we can make an impact with a new product that’s at least as good or better than what's currently available.

SmartTRAK: Are you talking from a feature and benefit perspective, in terms of competition?

JG: Yes, our internal R&D team works in collaboration with our surgeon and distributor partners to identify critical features and benefits for the implants as part of the initial process, but we also carefully examine the instrumentation needs. This process allows us to identify holes and opportunities for innovation across the full spectrum of a system. This holistic approach and hyper focus on all aspects of each instrument and implant ultimately delivers a new standard for intraoperative flexibility and versatility, which in turn has fueled our fast-paced growth ...

To download and read the rest of this fascinating interview with Joel Gambrell  in which "Astura Medical Reveals New Products Launching at NASS 2022", just click the button below.